Humedix Co., Ltd. (KOSDAQ:200670)

Market Cap	251.81B -41.8%
Revenue (ttm)	110.99B +12.7%
Net Income	9.06B -39.9%
EPS	963.99 -39.3%
Shares Out	10.32M
PE Ratio	25.31
Forward PE	6.20
Dividend	660.00 (2.70%)
Ex-Dividend Date	May 26, 2026

Volume	38,946
Open	24,400
Previous Close	24,400
Day's Range	24,400 - 26,850
52-Week Range	23,800 - 77,200
Beta	0.34
Analysts	Strong Buy
Price Target	62,000.00 (0.0%)
Earnings Date	Aug 13, 2026

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetics, and health functional food products. It is also involved in the manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 248
• Stock Exchange: KOSDAQ
• Ticker Symbol: 200670

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.